NSC |
Compound |
Enrichment |
Correlation |
NSC 707904 |
Null |
0.00140570135773563 |
-0.25858876 |
NSC 723732 |
8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one |
0.00140570135773563 |
-0.2505616 |
NSC 740 |
Methotrexate |
0.00140570135773563 |
-0.33570494 |
NSC 163424 |
4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- |
0.00172065213317242 |
-0.038753099 |
NSC 371777 |
Null |
0.00172065213317242 |
-0.13549088 |
NSC 647763 |
Jasplakinolide epoxide C |
0.00172065213317242 |
-0.092847741 |
NSC 705870 |
Null |
0.00172065213317242 |
-0.11804863 |
NSC 732954 |
Null |
0.00172065213317242 |
-0.14602073 |
NSC 741106 |
6-(3-Aminopropyl)-5,6-dihydro-9-methoxycarbonyl-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride |
0.00172065213317242 |
-0.10239566 |
NSC 87221 |
Actinomycin D, 2A-D-alloisoleucine- (9CI) |
0.00172065213317245 |
-0.11762788 |